Search research articles
Contact Us
Filters
Showing results (211-220 of 388) with videos related to
Page
of 39
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 7, 2015
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment
Francesca V Negri, Barbara Dal Bello, Camillo Porta, et al.
Journal for Immunotherapy of Cancer
|
June 28, 2022
Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors
Barbara Mandriani, Eleonora Pellè, Francesco Mannavola, et al.
Oncology Research
|
May 1, 2026
The Real-World Endocrine Toxicity Profile of ICIs, VEGFR-TKIs, and Their Combination: Analysis of the FDA Adverse Event Reporting System (FAERS) Database
Nicola Marrano, Mariangela Caporusso, Cosimo Matino, et al.
European Urology
|
September 17, 2020
Final Overall Survival Results from a Phase 3 Study to Compare Tivozanib to Sorafenib as Third- or Fourth-line Therapy in Subjects with Metastatic Renal Cell Carcinoma
Sumanta K Pal, Bernard J Escudier, Michael B Atkins, et al.
BMC Cancer
|
September 8, 2009
Concurrent intra-arterial carboplatin administration and radiation therapy for the treatment of advanced head and neck squamous cell carcinoma: short term results
Giulia Bertino, Antonio Occhini, Carlo Emilio Falco, et al.
International Journal of Oncology
|
July 2, 2011
Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial
Laura Ridolfi, Oscar Bertetto, Antonio Santo, et al.
Journal of Neuroendocrinology
|
October 1, 2021
The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability
Eleonora Lauricella, Mauro Cives, Alessandra Bracigliano, et al.
Virchows Archiv : an International Journal of Pathology
|
April 29, 2023
STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma
Stefano Marletta, Anna Caliò, Giuseppe Bogina, et al.
Oncology
|
June 9, 2012
A pooled analysis of sequential therapies with sorafenib and sunitinib in metastatic renal cell carcinoma
Frank Stenner, Rahel Chastonay, Heike Liewen, et al.
European Urology Oncology
|
July 24, 2019
Metastatic Renal Cell Carcinoma Rapidly Progressive to Sunitinib: What to Do Next?
Melissa Bersanelli, Roberto Iacovelli, Sebastiano Buti, et al.
Page
of 39
Search research articles
Search
Showing results (211-220 of 388) with videos related to
Sort By:
Page
of 39
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 7, 2015
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment
Francesca V Negri, Barbara Dal Bello, Camillo Porta, et al.
Journal for Immunotherapy of Cancer
|
June 28, 2022
Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors
Barbara Mandriani, Eleonora Pellè, Francesco Mannavola, et al.
Oncology Research
|
May 1, 2026
The Real-World Endocrine Toxicity Profile of ICIs, VEGFR-TKIs, and Their Combination: Analysis of the FDA Adverse Event Reporting System (FAERS) Database
Nicola Marrano, Mariangela Caporusso, Cosimo Matino, et al.
European Urology
|
September 17, 2020
Final Overall Survival Results from a Phase 3 Study to Compare Tivozanib to Sorafenib as Third- or Fourth-line Therapy in Subjects with Metastatic Renal Cell Carcinoma
Sumanta K Pal, Bernard J Escudier, Michael B Atkins, et al.
BMC Cancer
|
September 8, 2009
Concurrent intra-arterial carboplatin administration and radiation therapy for the treatment of advanced head and neck squamous cell carcinoma: short term results
Giulia Bertino, Antonio Occhini, Carlo Emilio Falco, et al.
International Journal of Oncology
|
July 2, 2011
Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial
Laura Ridolfi, Oscar Bertetto, Antonio Santo, et al.
Journal of Neuroendocrinology
|
October 1, 2021
The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability
Eleonora Lauricella, Mauro Cives, Alessandra Bracigliano, et al.
Virchows Archiv : an International Journal of Pathology
|
April 29, 2023
STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma
Stefano Marletta, Anna Caliò, Giuseppe Bogina, et al.
Oncology
|
June 9, 2012
A pooled analysis of sequential therapies with sorafenib and sunitinib in metastatic renal cell carcinoma
Frank Stenner, Rahel Chastonay, Heike Liewen, et al.
European Urology Oncology
|
July 24, 2019
Metastatic Renal Cell Carcinoma Rapidly Progressive to Sunitinib: What to Do Next?
Melissa Bersanelli, Roberto Iacovelli, Sebastiano Buti, et al.
Page
of 39